+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 65Years
All Genders
ID04597164

Study of Double Plasma Molecular Adsorption and Low-Dose Plasma Exchange in Adults With Hepatitis B-Related Acute-on-Chronic Liver Failure

Led by Third Affiliated Hospital, Sun Yat-Sen University · Updated on 2024-11-29

200

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of combining a Double Plasma Molecular Adsorption System DPMAS with sequential low-dose plasma exchange PE to treat patients with hepatitis B virus-related acute-on-chronic liver failure ACLF. This serious liver condition has a high mortality rate, and current effective treatments are limited mainly to liver transplantation. The study aims to provide evidence for this combination therapy as a potential treatment option. The study includes two groups one group of 100 patients will receive the combined DPMAS and low volume PE treatments along with comprehensive internal medical care. The DPMAS involves processing 5000 to 6000 milliliters of plasma, and the PE uses 1000 milliliters of fresh frozen plasma, with treatments administered three times. The other 100 patients will receive comprehensive internal medical treatment alone. This research is conducted across six medical centers. Participants will be monitored from the start of treatment through 12 weeks. Researchers will record symptoms, signs, lab test results, adverse events, and mortality or liver transplantation rates. They will also assess changes in the Model for End-Stage Liver Disease MELD score over this period. The study focuses on safety and clinical outcomes to understand how well the combination therapy works and its impact on patients living with HBV-related ACLF.

CONDITIONS

Brief Title

Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF

Research Team

W

Wenxiong Xu, Doctor

L

Liang Peng, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here